VEGF-D has also been shown to be up-regulated by mechanistic (formerly mammalian) target of rapamycin (mTOR), a master regulator of cell growth, proliferation, and survival that has been implicated in PAH, lymphangioleiomyomatosis (LAM), and cancer (66). This evidence concerns the gene MTOR and lymphangioleiomyomatosis.